Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.5%

4 terminated/withdrawn out of 47 trials

Success Rate

87.1%

+0.6% vs industry average

Late-Stage Pipeline

4 trials in Phase 3/4

Results Transparency

11%

3 of 27 completed trials have results

Key Signals

4 recruiting3 with results

Enrollment Performance

Analytics

N/A

24(82.8%)

Phase 4

3(10.3%)

Phase 3

1(3.4%)

Phase 1

1(3.4%)

29Total

N/A(24)

Phase 4(3)

Phase 3(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (47)

Showing 20 of 47 trials

NCT07091682Not ApplicableRecruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

Role: lead

NCT04679740Recruiting

Resorbable Magnesium Scaffolds Registry

Role: lead

NCT05540223Not ApplicableRecruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System

Role: lead

NCT03298659Not ApplicableActive Not Recruiting

iFR Guided Multi-vessel Revascularization During Percutaneous Coronary Intervention for Acute Myocardial Infarction

Role: collaborator

NCT06758921Recruiting

Prospective, Multicenter, Single-Arm Observational Study to Confirm the Safety and Clinical Performance of the Oscar Peripheral Multifunctional Catheter for the Dilatation of Lesions in the Femoral, Popliteal and Infrapopliteal Arteries (BIO-OSCAR First)

Role: lead

NCT05667285Terminated

BIOFLOW-china Post-marketing Study (BIOTRONIK)

Role: collaborator

NCT05831319Completed

Evaluation of Standard of Care Practices, Procedural Outcomes and In-hospital Complications of Peripheral Endovascular Procedures

Role: lead

NCT04555174Active Not Recruiting

BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry

Role: lead

NCT02249000Not ApplicableCompleted

BIOVALVE - I / II Clincial Investigation